Diagnosis and management of group B streptococcus in pregnancy.
Obstetrics and Gynecology Clinics of North America
Volume 41, Issue 4
Group B streptococcus (GBS) can cause significant maternal and neonatal morbidity. Over the past 30 years, reductions in early-onset GBS neonatal sepsis in the United States have been attributable to the guidelines from the Centers for Disease Control and Prevention for antepartum screening and treating this organism during labor. This article highlights the clinical implications, screening, diagnosis, prophylactic interventions, and future therapies for mothers with GBS during the peripartum period.
Ahmadzia, H.K., Heine, R.P. (2014). Diagnosis and management of group B streptococcus in pregnancy. Obstetrics and Gynecology Clinics of North America, 41(4), 629-647.